K180513

Substantially Equivalent

CustomizedBone Service

Applicant: Fin-Ceramica Faenza S.P.A.
Product code: GXN
Advisory panel: Neurology
Date received: 2018-02-27
Decision date: 2018-05-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Faenza, IT

Adverse events under product code GXN

product code GXN

Injury: 208
Total: 208

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.